Effect of Posterolateral Mini-incision Hip Hemiarthroplasty on Pain Scores and Hip Function in Elderly Patients With Hip Fractures

后外侧微创髋关节半置换术对老年髋部骨折患者疼痛评分和髋关节功能的影响

阅读:1

Abstract

OBJECTIVE: This study aimed to investigate the effect of posterolateral mini-incision hip hemiarthroplasty (HHA) on pain and hip function in elderly patients with hip fractures. METHODS: Sixty hip fracture patients treated at our hospital between January 2023 and January 2024 were randomly assigned to two groups, with 30 patients in each group. The control group underwent traditional posterolateral approach HHA, while the observation group received HHA using the posterolateral mini-incision approach. General data were collected from both groups. Surgical indicators, including surgical time, time to ambulation, and length of hospital stay, were compared between the two groups. Adverse reactions and postoperative complications were recorded. Postoperative pain was assessed using the Visual Analog Scale (VAS) 24 hours after surgery. Treatment efficacy was evaluated with the Harris Hip Score (HHS), and balance ability was assessed using the Berg Balance Scale. RESULTS: No significant differences were observed in baseline characteristics between the two groups (P > 0.05). The observation group demonstrated better surgical outcomes, with shorter operation and recovery times, as well as fewer adverse reactions and complications (P < 0.05). Postoperative VAS scores were significantly lower, and both HHS and Berg Balance Scale scores were higher in the observation group compared with the control group (P < 0.05). CONCLUSION: The posterolateral mini-incision approach for HHA in elderly patients with hip fractures can optimize surgical outcomes, reduce postoperative pain and complications, improve hip joint function, and promote better postoperative recovery, resulting in overall superior effects.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。